摘要
20世纪以来,随着医疗护理技术水平的不断提升,及经皮冠状动脉介入治疗(PCI)的不断发展,心肌梗死(心梗)的发病率和死亡率逐年下降。但由于全球人口老龄化的不断加重及不良的生活工作方式等因素,心梗仍是心力衰竭(心衰)最主要的病因之一,且心梗后年龄、性别、心率失常、高血压、糖尿病、慢性肾病等危险因素都会不同程度地导致心衰风险的增加。近10年来,中医疗法在防治心梗后心衰也有了新的见解,在“治未病”理论的指导下,针对心梗和心衰的病因病机给予中医药疗法,以达到未病先防,防重于治的目的,为中医药预防心梗后心衰提供了新思路,在“整体观念,辨证论治”理论的指导下,制定个体化诊疗方案,积极寻求行之有效的中西医疗法,为中西医治疗心梗后心衰提供了更加有效的保障。因此积极主动地进行规范化中西医治疗可以有效地降低心梗后心衰的发病率和死亡率,故此综述。
Since the 20th century, with the continuous improvement of medical and nursing technology, the continuous development of percutaneous coronary intervention (PCI) and the gradual improvement of technology, the incidence and mortality of myocardial infarction (MI) have decreased year by year. However, due to the increasing aging of the global population and poor lifestyle and other factors, myocardial infarction is still one of the main causes of heart failure (heart failure). After myocardial infarction, age, sex, arrhythmia, hypertension, diabetes, chronic kidney disease and other risk factors will increase the risk of heart failure in varying degrees. In the past decade, Chinese medicine therapy has also gained new insights in the prevention and treatment of heart failure after myocardial infarction. Guided by the theory of “preventing diseases before they occur”, Chinese medicine therapy has been administered based on the etiology and pathogenesis of myocardial infarction and heart failure, aiming to prevent diseases before they occur, with prevention as the priority. This provides a new way of thinking for Chinese medicine to prevent heart failure after myocardial infarction. Under the guidance of the theory of “holistic view and syndrome differentiation and treatment”, individualized diagnosis and treatment plans are formulated, and effective Chinese and Western medical treatments are actively sought, providing more effective guarantees for the treatment of heart failure after myocardial infarction with both Chinese and Western medicine. Therefore, proactive standardized Chinese and Western medicine treatment can effectively reduce the incidence and mortality of heart failure after myocardial infarction. Hence, this is a summary of the topic.
出处
《临床医学进展》
2024年第5期1466-1474,共9页
Advances in Clinical Medicine